{
    "title": "Glaxo gets a boost as EU regulators recommend approval for new HIV prevention drug Apretude",
    "url": "https://www.dailymail.co.uk/money/markets/article-12334489/Glaxo-gets-boost-EU-regulators-approve-new-HIV-prevention-drug-Apretude-sale.html",
    "date": "2023-07-25",
    "keywords": [
        "prevention",
        "treatment",
        "share",
        "fund",
        "glaxosmithkline",
        "shot",
        "arm",
        "gsk",
        "protection",
        "injection",
        "glaxo",
        "virus",
        "cabenuva",
        "investment",
        "account",
        "fee",
        "dose",
        "news",
        "ftse",
        "firm",
        "executive",
        "emma",
        "walmsley",
        "cabotegravir",
        "drug",
        "viiv",
        "healthcare",
        "sale",
        "agency",
        "brand",
        "name",
        "apretude",
        "south",
        "malawi",
        "botswana",
        "infection",
        "vaccine",
        "approval",
        "rsv",
        "jab",
        "lawsuit",
        "claimant",
        "pharma",
        "giant",
        "hunt",
        "takeover",
        "article",
        "year",
        "day",
        "level",
        "expansion",
        "epidemic",
        "europe",
        "choice",
        "head",
        "research",
        "viivs",
        "hiv",
        "use",
        "uk",
        "institute",
        "health",
        "care",
        "excellence",
        "diy",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}